Cocaine infusion increases interferon-γ and decreases interleukin-10 in cocaine-dependent subjects

Clinical Immunology and Immunopathology

Volumn 89, Issue 2, 1998, Pages 181-190

  Gan, Xiaohu ^a   Zhang, Ling ^a   Newton, Thomas ^a   Chang, Sulie L ^b   Ling, Walter ^a   Kermani, Vali ^c   Berger, Omri ^a   Graves, Michael C ^a   Fiala, Milan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SETON HALL UNIVERSITY   (United States)

^c Immunobiogen Inc   (United States)

Author keywords

Cocaine; Interferon ; Interleukin 10

Indexed keywords

ALCOHOL; COCAINE; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; DOPAMINE; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; NORADRENALIN; PHORBOL ESTER; PHYTOHEMAGGLUTININ; PRASTERONE SULFATE; PROLACTIN; REACTIVE OXYGEN METABOLITE; SEROTONIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ADULT; APOPTOSIS; ARTICLE; BINDING COMPETITION; BRAIN VASCULITIS; CATECHOLAMINE UPTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREGULATION; INTRAVENOUS DRUG ABUSE; LEUKOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031735075     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4607     Document Type: Article

References (42)

1. Gawin F. H. Cocaine addiction: Psychology and neurophysiology. Science. 251:1991;1580-1586.
2. Weiss S. H. Links between cocaine and retroviral infection. JAMA. 262:1989;607-609.
3. Di Francesco P., Marini S., Pica F., Favalli C., Tubaro E., Garaci E. In vivo. Immunol. Res. 11:1992;74-79.
4. Wang Y., Huang D. S., Watson R. R. In vivoin vitro. Life Sci. 54:1994;401-411.
5. Phirozhkov S. V., Watson R. R., Chen G. J. Ethanol enhances immuno-suppression induced by cocaine. Alcohol. 6:1992;489-494.
6. Donahoe R. M., Falek A., Madden J. J., Nicholson J. K., Bokos P., Gallegos K., Veit K. Effects of cocaine and other drugs of abuse on immune function. Adv. Exp. Med. Biol. 288:1991;143-150.
7. Carroll F. I., Lewin A. H., Boja J. W., Kuhar M. J. Cocaine receptor: Biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. J. Med. Chem. 35:1992;979-981.
8. Koe B. K. Molecular geometry of inhibitors of uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199:1976;649-661.
9. Moldow R. L., Fishman A. J. Cocaine-induced secretion of ACTH, beta-endorphin and corticosterone. Peptides. 8:1987;819-822.
10. Heesch C. M., Negus B. H., Keffef J. H., Snyder R. W., Risser R. C., Eichhorn E. J. Effects of cocaine on cortisol secretion in humans. Am. J. Med. Sci. 310:1995;61-64.
11. Rivier C., Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing mechanism. Brain Res. 422:1987;403-406.
12. Bayer B. M., Mulroney S. E., Hernandez M. C., Ding X. Z. Acute infusions of cocaine result in time and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats. Immunopharmacology. 29:1995;19-28.
13. Wu Y. B., Shen M. L., Gu G. G., Anderson K. M., Ou D. W. The effects of cocaine injections on mouse thymocyte sub-populations. Proc. Soc. Exp. Biol. Med. 214:1998;173-179.
14. Vaz A., Lefkowitz S. S., Castro A., Lefkowitz D. L. The effects of cocaine and its metabolites on the production of reactive oxygen and reactive nitrogen intermediates. Life Sci. 55:1994;439-444.
15. Ruiz P., Cleary T., Nasiri M., Steele B. Human T lymphocyte sub-population and NK cells alterations in persons exposed to cocaine. Clin. Immunol. Immunopathol. 70:1994;245-250.
16. Van Dyke C., Stesin A., Jones R., Chuntharapai A., Seaman W. Cocaine increases natural killer cell activity. J. Clin. Invest. 77:1986;1387-1390.
17. Mosmann T. R., Coffman R. L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46:1989;111-147.
18. +. Immunol. Rev. 123:1991;209-229.
19. Moore K. W., O'Gara A., deWaal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Ann. Rev. Immunol. 11:1993;165-190.
20. Shearer G. M., Clerici M. Protective immunity against HIV infection. Immunol. Today. 17:1996;21-25.
21. Heinzel F. P., Sadick M. D., Mutha S. S., Locksley R. M. Production of interferon-γ, interleukin-2, interleukin-4, and interleukin-10 by CD4 positive lymphocytesin vivo. Proc. Natl. Acad. Sci. USA. 88:1991;7011-7015.
22. Yamamura M., Wang X-H., Ohmen J. D., Uyemura K., Rea T. H., Bloom B. R., Modlin R. L. Cytokine patterns of immunologically mediated tissue damage. J. Immunol. 149:1992;1470-1475.
23. Bloom B. R., Modlin R. L., Salgame P. Stigma variations: Observations on suppressor T cells and leprosy. Ann. Rev. Immunol. 10:1992;453-488.
24. Sieling P. A., Abrams J. S., Yamamura M., Salgame P., Bloom B. R., Rea T. H., Modlin R. L. Immunosuppressive roles for IL-10 and IL-4 in human infection.In vitro. J. Immunol. 150:1993;5501-5510.
25. Gan X-H., Robin J. P., Huerta J. M. M., Braquet P., Bonavida B. Inhibition of TNF-α and IL-1β secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative. J. Clin. Immunol. 14:1994;280-288.
26. Altman D. G. Practical Statistics for Medical Research. 1991;Chapman & Hall, London. p. 521-522.
27. Friedman H. Drugs of abuse as possible co-factors in AIDS progression: Summary of panel discussion. Adv. Exp. Med. Biol. 402:1996;225-228.
28. Di Franco M. J., Sheppard H. W., Hunter D. J., Tosteson T. D., Ascher M. S. The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco men's health study. Ann. Epidemiol. 64:1996;283-289.
29. Pellegrino T., Bayer B. M. In vivo. J. Neuroimmunol. 83:1998;139-147.
30. Stanulis E. D., Matulka R. A., Jordan S. D., Rosecrans J. A., Holsapple M. P. Role of corticosterone in the enhancement of the antibody response following acute cocaine administration. J. Pharmacol. Exp. Ther. 280:1996;284-291.
31. Stanulis E. D., Jordan S. D., Rosecrans J. A., Holsapple M. P. Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone. Immunopharmacology. 37:1997;25-33.
32. Clouse K. A., Powell D., Washington I., Poli G., Strebel K., Farrar W., Barstad P., Kovacs J., Fauci A. S., Folks T. M. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T-cell clone. J. Immunol. 142:1989;431-438.
33. Folks T. M., Clouse K. A., Justement J., Rabson A., Duh E., Kehrl J. H., Fauci A. S. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA. 86:1989;2365-2368.
34. Duh E. J., Mauty W. J., Folks T. M., Fauci A. S., Rabson A. B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA. 86:1989;5974-5978.
35. Griffin G. E., Leung K., Folks T. M., Kunkel S., Nabel G. J. Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature. 339:1989;70-73.
36. Osborn G. J., Kunkel S., Nabel G. J. Tumor necrosis factor alpha and IL-1 activate the human immunodeficiency virus enhancer by activation of the nuclear factor NF-κB. Proc. Natl. Acad. Sci. USA. 86:1989;2336-2340.
37. Weissman D., Poli G., Fauci A. S. Interleukin-10 blocks HIV replication in macrophages by inhibiting the autocrine loop of TNF-a and IL-6 induction of virus. AIDS Res. Hum. Retrovir. 10:1994;1199-1206.
38. Matsuyama T., Hamamoto Y., Soma G-I., Mizuno D., Yamamoto N., Kobayashi N. Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodefficiency virus (HIV): Enhancement of HIV replication. J. Virol. 63:1989;2504-2509.
39. d'Andrea A., Rengaraju N., Valiante N. M., Chehimi J., Kubind M., Aste M., Chan S. H., Kobayashi M., Young D., Nickbarg E., Chizzonite R., Wolf S. F., Trinchieri G. Production of natural killer cell stimulatory factor (IL-12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1992;1387-1398.
40. Mosmann T. R. Properties and function of interleukin-10. Adv. Immunol. 56:1994;1-26.
41. Mao J. T., Huang M., Wang J., Sharma S., Tashkin D. P., Dubinett S. M. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-γ production. Cell. Immunol. 172:1996;217-223.
42. Bussiere J. L., Adler M. W., Rogers T. J., Eisenstein T. K. Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacol. Immunotoxicol. 14:1992;657-673.